試す 金 - 無料
The fall of Biden
Business Standard
|April 14, 2025
Over St. Patrick's Day weekend in 2024, US President Joe Biden hosted the traditional gathering of Irish and Irish American politicians in the White House.
Over St. Patrick's Day weekend in 2024, US President Joe Biden hosted the traditional gathering of Irish and Irish American politicians in the White House. This was home ground for Biden, the most ostentatiously Irish figure ever to occupy the Oval Office. He should have been able to schmooze his way through it on autopilot. Yet he had to use a teleprompter for his remarks. Even in the friendliest and least stressful of public environments, he could not risk the possibility of losing track of what he was saying.
In his lively, engaging but sometimes frustrating chronicle of the 2024 presidential election campaign, Chris Whipple records the incredulity of one of those at the gathering, Barack Obama's former chief of staff Bill Daley: "If the president needed a script for a small gathering of Irish guys, how would he survive the rigors of a campaign? 'How are they letting this thing go on?' he thought. 'This is crazy.'"
Elsewhere in Whipple's narrative, Daley expresses his anger at those around Biden in rather more earthy terms: "Every freaking one of them had no balls."
Whipple's previous book, The Fight of His Life (2023), is a sympathetic account of Biden's first two years in office, written with the obvious cooperation of his inner circle. It is thus unsurprising that Uncharted is most vivid when recreating the drama of the president's stubborn refusal to realize that he was in no condition to stand against Donald Trump last November.
このストーリーは、Business Standard の April 14, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Business Standard からのその他のストーリー
Business Standard
Nalco urges Odisha govt to expedite land handover process for ‘30K cr projects
Navratna central public-sector enterprise (CPSE) Nalco has requested the Odisha government to expedite the land handover process for its 30,000 crore expansion projects that will boost capacity and help it achieve the Maharatna status by 2030.
1 mins
March 10, 2026
Business Standard
Women-led startups saw 9% funding drop in 2025
Female labour participation just 42%, among lowest in G20: Axis Bank study
3 mins
March 10, 2026
Business Standard
How India can kick the West Asian oil habit
Increasing the use of alternative fuels like ethanol could be one way out
6 mins
March 10, 2026
Business Standard
India’s T20 WC win brings new stars to brand crease
\"Sachin Tendulkar carried Indian cricket on his shoulders for 21 years.
3 mins
March 10, 2026
Business Standard
UBS downgrades OMCs as oil crosses $100/bbl
The recent rally in crude prices and refining margins create a sense of déjà vu, UBS said, mirroring the 2022 oil market disruption.
1 min
March 10, 2026
Business Standard
LIC drove 18% rise in life insurers’ NBP in Feb
New business premium of life insurance companies grew 18 per cent year-on-year (Y-o-Y) to ₹35,417 crore in February, driven by robust growth at the state-owned Life Insurance Corporation of India (LIC) due to a favourable base.
1 mins
March 10, 2026
Business Standard
Why India needs Russian oil
India's oil security is becoming increasingly fragile. Over 80 per cent of its crude imports come from just two suppliers — West Asia and Russia — both now facing geopolitical stress. In this environment, resuming full purchases of Russian oil may not be a choice but a necessity. Here are eight reasons why.
3 mins
March 10, 2026
Business Standard
India, Uzbekistan launch pharma-nutra corridor
India and Uzbekistan on Monday launched a structured pharmaceutical and nutraceutical trade corridor aimed at expanding access to the Commonwealth of Independent States (CIS) and the wider Eurasian healthcare market, estimated at $7-10 billion.
1 min
March 10, 2026
Business Standard
A clear derating
Markets risk underperformance if we don’t regain our growth credentials
5 mins
March 10, 2026
Business Standard
Delhi HC allows Dr Reddy’s to make semaglutide for export
A division Bench of the Delhi High Court on Monday affirmed a single-judge Bench’s order allowing pharmaceutical company Dr Reddy’s Laboratories to manufacture the diabetes and weight-management drug semaglutide in India for export to jurisdictions where Danish drugmaker Novo Nordisk does not have patent protection.
2 mins
March 10, 2026
Listen
Translate
Change font size
